- Home
- MAV vs LXRX Comparison
MAV vs LXRX Comparison
Compare MAV & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAV
- LXRX
- Stock Information
- Founded
- MAV 2003
- LXRX 1995
- Country
- MAV United States
- LXRX United States
- Employees
- MAV N/A
- LXRX N/A
- Industry
- MAV Finance Companies
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MAV Finance
- LXRX Health Care
- Exchange
- MAV Nasdaq
- LXRX Nasdaq
- Market Cap
- MAV 198.7M
- LXRX 228.8M
- IPO Year
- MAV N/A
- LXRX 2000
- Fundamental
- Price
- MAV $8.34
- LXRX $0.91
- Analyst Decision
- MAV
- LXRX Buy
- Analyst Count
- MAV 0
- LXRX 4
- Target Price
- MAV N/A
- LXRX $3.67
- AVG Volume (30 Days)
- MAV 66.2K
- LXRX 5.2M
- Earning Date
- MAV 01-01-0001
- LXRX 07-31-2025
- Dividend Yield
- MAV 4.30%
- LXRX N/A
- EPS Growth
- MAV N/A
- LXRX N/A
- EPS
- MAV N/A
- LXRX N/A
- Revenue
- MAV N/A
- LXRX $31,213,000.00
- Revenue This Year
- MAV N/A
- LXRX N/A
- Revenue Next Year
- MAV N/A
- LXRX N/A
- P/E Ratio
- MAV N/A
- LXRX N/A
- Revenue Growth
- MAV N/A
- LXRX 1251.21
- 52 Week Low
- MAV $6.37
- LXRX $0.28
- 52 Week High
- MAV $8.34
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- MAV 57.62
- LXRX 60.89
- Support Level
- MAV $8.27
- LXRX $0.80
- Resistance Level
- MAV $8.32
- LXRX $0.96
- Average True Range (ATR)
- MAV 0.05
- LXRX 0.08
- MACD
- MAV 0.00
- LXRX 0.01
- Stochastic Oscillator
- MAV 80.00
- LXRX 78.79
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax, and as a secondary objective, to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.